| A45 | Baricitinib reduces macrophage-mediated inflammation in HIV infection | E-poster | Co-morbidities: Non-communicable diseases |
| A45 | BMI as a predictor of high fasting blood glucose among people living with HIV in the Asia-Pacific region | E-poster | Co-morbidities: Non-communicable diseases |
| A43 | SARS-Cov-2 immunity in COVID-19 convalescent individuals living with HIV: bulk immune profiling and SARS-CoV-2 specific humoral and cellular immune responses | Oral abstract session with live Q&A | Co-infection: SARS-Co-V2 |
| A43 | SARS-CoV-2-seronegative subjects target CTL epitopes in the SARS-CoV-2 nucleoprotein cross-reactive to common cold coronaviruses | Oral abstract session with live Q&A | Co-infection: SARS-Co-V2 |
| A43 | Systematic review: COVID-19 and HIV, risk of hospitalization/ICU admission and mortality | E-poster | Co-infection: SARS-Co-V2 |
| A43 | Sars-COV-2 and HIV in Brazil: a dangerous combination | E-poster | Co-infection: SARS-Co-V2 |
| A42 | High prevalence of bacterial sexually transmitted infections among Brazilian adolescents' men who have sex with men in Northeast Brazil | E-poster | Co-infection: STIs, including HPV |
| A42 | Bacterial STI rates by pharyngeal, urethral and rectal sites among adolescents' men who have sex with men in Northeast Brazil: the importance of comprehensive sample collection sites | E-poster | Co-infection: STIs, including HPV |
| A41 | Viral hepatitis cascade of care among adults living with HIV in Asia-Pacific | Oral abstract session with live Q&A | Co-infection: Viral hepatitis |
| A41 | T cell maturation and senescence evolution after HCV elimination in HIV-HCV patients | E-poster | Co-infection: Viral hepatitis |